menu
    • menu

    Company profile for MAIA Biotechnology

    NEW Drugs in Dev: 3
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MAIA Biotechnology, Inc. is a targeted therapy, immuno-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. A privately-held company based in Chicago, MAIA is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to adv...
    MAIA Biotechnology, Inc. is a targeted therapy, immuno-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. A privately-held company based in Chicago, MAIA is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to advancing promising agents into clinical trials. MAIA’s business model involves placing drug candidates in their own dedicated, R&D focused subsidiary company, which is supported by the common infrastructure.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MAIA BiotechnologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    444 West Lake Street Suite 1700 Chicago, IL 60606
    Telephone
    Telephone
    (312) 416-8592
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://maiabiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/organization-guest/company/maiabiotech/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PCHi

    PCHi

    Not Confirmed

    envelop Contact Supplier

    PCHi

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MAIA Bio Plans Public Stock Offering And Pre-Funded Warrants
    MAIA Bio Plans Public Stock Offering And Pre-Funded Warrants

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247913/0/en/MAIA-Biotechnology-Announces-Proposed-Underwritten-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    MAIA Bio's Phase 3 Shows Promise In $50B Immunotherapy Market
    MAIA Bio's Phase 3 Shows Promise In $50B Immunotherapy Market

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243622/0/en/MAIA-Biotechnology-s-Phase-3-Momentum-Demonstrates-Potential-Breakthrough-Anticancer-Opportunity-in-50-Billion-Immunotherapy-Market.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    MAIA Biotech Advances Ateganosine, Targeting 2026 Milestone
    MAIA Biotech Advances Ateganosine, Targeting 2026 Milestone

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221963/0/en/MAIA-Biotechnology-Advances-Ateganosine-Cancer-Treatment-Program-Outlines-Targeted-2026-Clinical-Milestones-and-Growth-Momentum.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    MAIA Bio Board Members Engage In Private Placement Financings
    MAIA Bio Board Members Engage In Private Placement Financings

    24 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/24/3210313/0/en/MAIA-Biotechnology-Board-Members-Continue-to-Participate-in-Private-Placement-Financings.html

    GLOBENEWSWIRE
    24 Dec 2025
    Share Share
    MAIA Biotechnology Announces $1.51 Million Private Placement
    MAIA Biotechnology Announces $1.51 Million Private Placement

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206621/0/en/MAIA-Biotechnology-Announces-1-51-Million-Private-Placement.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    MAIA Bio Initiates THIO-104 Ph 3 Trial For Ateganosine
    MAIA Bio Initiates THIO-104 Ph 3 Trial For Ateganosine

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203966/0/en/MAIA-Biotechnology-Announces-First-Patient-Dosed-in-THIO-104-Phase-3-Pivotal-Trial-Evaluating-Ateganosine-as-Third-Line-Treatment-for-Advanced-Non-Small-Cell-Lung-Cancer.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search